Huang S M, Marriott T B, Weintraub H S, Boccagno J A, Abels R
Research Laboratories, Ortho Pharmaceutical Corporation, Raritan, NJ 08869-0602.
Int J Clin Pharmacol Ther Toxicol. 1988 Mar;26(3):113-7.
A three-way crossover study was conducted in 24 normal, male volunteers to compare the bioavailability of etintidine from capsules (2 X 200 mg) taken under fasting conditions, with food and with milk. Blood samples were collected prior to and at various times after each treatment and plasma levels of etintidine were determined by high performance liquid chromatography. Statistical analysis of the plasma etintidine concentration data indicated that while neither food nor milk had an apparent effect (p greater than 0.05) on the rate of etintidine absorption, both food alone and milk alone slightly decreased the extent of etintidine absorption. Mean bioavailability parameters of etintidine obtained following the administration of etintidine with food, milk or under fasting conditions are 5.28, 5.26 and 5.88 micrograms.h/ml, respectively (for AUC) and 1.75, 2.18 and 2.59 micrograms/ml, respectively (for Cmax), and 1.23, 1.01 and 0.91 h, respectively (for tmax). Symmetrical 95% confidence interval analyses showed that the observed decreases of less than 11% in the AUC values of etintidine following the concomitant administration of food or milk were within 17% of the fasting value and, therefore, may not be of clinical significance.
在24名正常男性志愿者中进行了一项三交叉试验,以比较空腹服用、与食物同服以及与牛奶同服时,胶囊剂(2×200毫克)中乙溴替丁的生物利用度。在每次治疗前及治疗后的不同时间采集血样,采用高效液相色谱法测定血浆中乙溴替丁的水平。对血浆乙溴替丁浓度数据的统计分析表明,食物和牛奶对乙溴替丁的吸收速率均无明显影响(p>0.05),但单独食物和单独牛奶均会轻微降低乙溴替丁的吸收程度。在与食物、牛奶同服或空腹服用乙溴替丁后获得的乙溴替丁平均生物利用度参数分别为:AUC(曲线下面积)分别为5.28、5.26和5.88微克·小时/毫升,Cmax(最大血药浓度)分别为1.75、2.18和2.59微克/毫升,tmax(达峰时间)分别为1.23、1.01和0.91小时。对称95%置信区间分析表明,与食物或牛奶同服后乙溴替丁AUC值下降不到11%,在空腹值的17%以内,因此可能无临床意义。